Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global neurovascular embolization market 3600 synopsis, 2018 – 2032
2.2 Regional trends
2.3 Product trends
2.4 Procedure trends
2.5 End-use trends
Chapter 3 Neurovascular Embolization Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increasing incidence of neurovascular diseases
3.5.1.2 Technological advancements in the neurovascular embolization devices
3.5.1.3 Increasing research activities for neurovascular therapies
3.5.1.4 Growing awareness regarding neurovascular embolization procedures
3.5.2 Industry pitfalls & challenges
3.5.2.1 High cost of neurovascular surgeries and associated products
3.5.2.2 Stringent regulatory scenario
3.6 Growth potential analysis
3.6.1 By product
3.6.2 By procedure
3.6.3 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Medtronic
4.1.2 Stryker
4.1.3 Cerenovus (Johnson & Johnson)
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Neurovascular Embolization Market Size and Forecast, By Product, 2018-2032 (USD Million & Units)
5.1 Key trends, by product
5.2 Embolic coils
5.3 Flow diversion devices
5.4 Liquid embolic agents/systems
5.5 Aneurysm clips
5.6 Intrasaccular flow disruptors
Chapter 6 Neurovascular Embolization Market Size and Forecast, By Procedure, 2018-2032 (USD Million)
6.1 Key trends, by procedure
6.2 Aneurysm coiling and embolization
6.3 Arteriovenous malformation (AVM) embolization
6.4 Other procedures
Chapter 7 Neurovascular Embolization Market Size and Forecast, By End-use, 2018-2032 (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Specialty clinics
7.4 Other end-users
Chapter 8 Neurovascular Embolization Market Size and Forecast, By Region, 2018-2032 (USD Million & Units)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Medtronic
9.2 Stryker
9.3 Cerenovus (Johnson & Johnson)
9.4 Integra LifeSciences
9.5 Penumbra Inc
9.6 Balt SAS
9.7 B. Braun Melsungen AG
9.8 Phenox GmbH
9.9 MicroVention Inc (Terumo Corporation)
9.10 Shape Memory Medical Inc
9.11 Peter Lazic GmbH
9.12 Spartan Micro
